Disagree
Home Hemi Pharma Hemi Pharma
BPC-157
BPC-157 - Hemi Pharma

BPC-157 - Hemi Pharma

Brand:
Category:
Substance:
Package:
5 mg
Price:
$42.00 - $42.00
See options
Product Overview
The roots of BPC-157 trace back to the early 1990s, when Croatian scientist Predrag Sikiric began formal investigation into its properties. It was created as a synthetic version of a peptide fragment naturally found in human gastric secretions and was noted for its ability to support tissue regeneration. Backed by Pliva Pharmaceuticals until 2005, the compound was later eyed by Merck, though no acquisition followed. Since then, BPC-157 entered the research chemical space, with Slovenian firm Diagen emerging as a principal source.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about BPC-157 by Hemi Pharma, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What was BPC-157 originally designed to treat?
It was explored for its potential in accelerating tissue regeneration, including muscle, tendon, and nerve healing.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Did BPC-157 ever reach clinical approval as a drug?
No, it was never approved for medical use and remains available only as a research compound.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Which company currently manufactures most BPC-157?
Today, it is primarily produced and distributed by Diagen, a company based in Slovenia.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.